Treasury Rules Throw $160 Billion Merger Into Doubt

Treasury Rules Throw $160 Billion Merger Into Doubt

The pending $160 billion merger between Pfizer (PFE) and Allergan (AGN), announced in November is the second-biggest deal of all time. “The merger between the two companies would shift Pfizer’s headquarters to Ireland, a move that could reduce its tax bill.” “The structure is emblematic of the tax inversion deals that have become popular in recent years.”

Advertisements